First patient randomized in an international double-blind Phase III cardiac surgery study
The study, sponsored by a European biopharmaceutical company and managed by GCT in Russia has got off the ground. Recently, the leading Russian Cardiology Institute has randomized the first patient in the study.
November 13, 2018
Meet our clients
All trademarks, brand names and logotypes are intellectual property of their respective owners.
Upcoming meetings
-
ISCR Summit
Taj Lands End
Mumbai, India
2020, January 24—25 -
Global Oncology Site Solutions Summit
Hilton Austin
Austin, Texas, USA
2020, January 31 — February 1 -
ISCTM 16 Annual Scientific Meeting
Grand Hyatt
Washington, District of Columbia, USA
2020, January 18—19 -
European Site Solutions Summit
Hotel Cascais Miragem
Lisbon, Portugal
2020, March 9—10
